Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Oncology

PDF

University of Texas MD Anderson Cancer Center

2011

Antibodies, Monoclonal

Articles 1 - 3 of 3

Full-Text Articles in Medicine and Health Sciences

Oncolog, Volume 56, Number 04-05, April-May 2011, Zach Bohannan, Bryan Tutt Apr 2011

Oncolog, Volume 56, Number 04-05, April-May 2011, Zach Bohannan, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

  • Understanding and Managing Multiple Endocrine Neoplasia Syndromes: Endocrine tumors caused by multiple endocrine neoplasia syndromes (MEN) pose a dual threat-both from the tumors' potential for growth or metastasis and from their hormonal secretions
  • Two-Stage Resection and Improved Chemotherapy Regimens Lengthen Survival for Patients with Lever Metastasis from Colorectal Cancer
  • HOUSE CALL: Saving a Life by Donating Stem Cells: Fact about stem cell transplants
  • IN BRIEF: Study Reveals How EZH2 Protein Promotes Breast Tumor-Initiating Cell Growth


Oncolog, Volume 56, Number 02, February 2011, Joe Munch, John Lebas Feb 2011

Oncolog, Volume 56, Number 02, February 2011, Joe Munch, John Lebas

OncoLog MD Anderson's Report to Physicians (All issues)

  • Risk-Based Cancer Screening: M.D. Anderson's revised guidelines offer more precise individualized recommendations on screening for common cancers.
  • Screen Guidelines in Brief
  • Electronic Navigation Biopsy for Peripheral Lung Lesion Diagnosis
  • House Call: Couples and Cancer: Cancer-Related Issues Can Disrupt Relationships
  • in Brief: Researchers Find Glioblastoma's Resistance to Treatment Rooted in Immunosuppression


Oncolog, Volume 56, Number 01, January 2011, Bryan Tutt, Sunni Hosemann Jan 2011

Oncolog, Volume 56, Number 01, January 2011, Bryan Tutt, Sunni Hosemann

OncoLog MD Anderson's Report to Physicians (All issues)

  • New Drug Control Symptoms of Myeloproliferative Disorders and Improve Quality of Life for Patients: Recent clinical trials have demonstrated that a new class of drugs can effectively treat myeloproliferative disorders
  • Compass: Metastatic Melanoma: Experimental treatments could be preferable to standard therapies for metastatic melanoma
  • HOUS CALL: Breast Awareness: Guidelines recommend breast awareness rather than formal self-exams